Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

User Fee Package Offers FDA Reforms From A House Wary Of FDA Power

Mar 19 2012

• By Derrick Gingery

Related Content

Internet Promotions Must Be Redesigned After FDA Cites Sponsored Web Links

Apr 13 2009

Off-Label Use Discussions Should Stay Off-line, FDA Draft Guidance Says

Jan 02 2012

FDA’s Guidance Document To-Do List Grows

Mar 12 2012

FDA Expanding Accelerated Approval Through Guidance, Collaboration

Mar 12 2012

Antibiotics Stewardship Remains Open Question On Capitol Hill

Mar 19 2012

Drug Shortages Endgame: FDA Goes On Offensive As Legislative Plot Thickens

Mar 19 2012

Generic User Fee Waivers Created In Draft House Bill, Breaking FDA-Industry Agreement

Mar 19 2012

Conflict Of Interest Rules Get Clean Sweep In House Draft User Fee Bill

Mar 19 2012

FDA Pediatric Incentives, Powers Would Become Permanent Under Draft Bill

Mar 19 2012

FDA Biosimilars Guidances Address Immunogenicity Studies, European Bridge Data, Analytics

Feb 13 2012

PDUFA V: Can FDA Fight Off Mission Creep This Cycle?

Feb 06 2012

GMP Third-Party Audits Offered In Draft Senate User Fee Legislation

Mar 16 2012

BIO’s "Big Ideas" For FDA Reform Are Too Big For PDUFA

Jul 04 2011

As Some Pharma Companies Exit Facebook, Device Firms Stay Connected

Aug 22 2011

Additional Topics

United States Legislation BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window